Search

Your search keyword '"CHEN, H.-C."' showing total 2,469 results

Search Constraints

Start Over You searched for: Author "CHEN, H.-C." Remove constraint Author: "CHEN, H.-C."
2,469 results on '"CHEN, H.-C."'

Search Results

4. The TALAPRO-3 study design: a plain language summary.

5. The Gaia-ESO Survey: Extracting diffuse interstellar bands from cool star spectra, DIB-based interstellar medium line-of-sight structures at the kpc scale

9. The crystal growth and characterization of NaxCoO2 and NaxCoO2yH2O

10. Quantum Holonomy in Three-dimensional General Covariant Field Theory and Link Invariant

15. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

18. RpoS contributes in a host-dependent manner to Salmonella colonization of the leaf apoplast during plant disease

19. 1368P TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit

24. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

26. P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY

30. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

31. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (vol 12, 278, 2022)

37. Xpros: a Fuzzy Expert System for Prospect Appraisal XPROS : un système expert flou pour l'évaluation de prospects

39. Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: A proof-of-principle study

44. TALAPRO-3: A phase 3, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)

45. 645TiP TALAPRO-3: A phase III, double-blind, randomized study of enzalutamide (ENZA) plus talazoparib (TALA) vs placebo plus ENZA in patients (pts) with DDR gene mutated metastatic castration-sensitive prostate cancer (mCSPC)

47. 580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity

Catalog

Books, media, physical & digital resources